I can give the hon. Gentleman an absolute assurance that she will do so. In the case of valproate it is very clear what the next steps should be, because there is no dispute over the science. When there is controversy over the science—and I appreciate how distressing that is for the families involved—the first thing we must do is establish the truth of the situation, and that is why we have given Baroness Cumberlege a free hand to look at the whole issue.
Medicines and Medical Devices Safety Review
Proceeding contribution from
Jeremy Hunt
(Conservative)
in the House of Commons on Wednesday, 21 February 2018.
It occurred during Ministerial statement on Medicines and Medical Devices Safety Review.
Type
Proceeding contribution
Reference
636 c174 
Session
2017-19
Chamber / Committee
House of Commons chamber
Subjects
Librarians' tools
Timestamp
2020-07-09 15:43:05 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022158000270
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022158000270
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022158000270